Fig. 8From: Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancerDistribution of L/B ratios by molecular subtype in the 20 known invasive cancers for 99mTc sestamibi (r s = 0.12, p = 0.63) and 99mTc maraciclatide (r s = −0.12, p = 0.64)Back to article page